Search Results 1001-1010 of 15083 for transexamic

  1. Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors - Mayo Clinic

    The purpose of this research is to see how well fruquintinib works in combination with tislelizumab in participants with metastatic colorectal cancer (mCRC).

  2. Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization - Mayo Clinic

    About this study. The purpose of this trial is to determine the safety and efficacy of eculizumab in the prevention of antibody mediated rejection (AMR) in ...

  3. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Fruquintinib in Patients with Solid Tumors - Mayo Clinic

    The study is an open-label, dose escalation clinical trial to evaluate the safety, tolerability, and PK of fruquintinib in patients with advanced solid tumors.

  4. Integrative Medicine and Health - Conditions treated - Mayo Clinic

    Learn how integrative medicine and health practices are used to help enhance well-being and ease symptoms such as fatigue, nausea, pain and anxiety.

  5. A Study Comparing Sodium Nitroprusside and Nitroglycerin to Determine the Dose of Each Needed to get the Same Response - Mayo Clinic

    The purpose of this study is to find the doses needed of sodium nitroprusside and nitroglycerin to get an equal response, assessed by forearm blood flow.

  6. Mayo Clinic

    Home · YouTube-Gonda - Mayo Clinic Patient Video Guide - Minnesota ...

  7. Triple-Negative Breast Cancer Clinical Trials - Mayo Clinic Research

    Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as atezolizumab, may interfere ...

  8. A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of Chronic Spontaneous Urticaria in Adults Inadequately Controlled by H1-antihistamines - Mayo Clinic

    A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of Chronic Spontaneous Urticaria in Adults Inadequately Controlled by H1-antihistamines.

  9. Long-term Safety and Effectiveness Study for Participants with Advanced Tumors who are Currently on Treatment or in Follow-up in a Pembrolizumab Trial - Mayo Clinic

    The purpose of this study is to evaluate the long-term safety and efficacy of pembrolizumab (MK-3475) in participants from previous Merck pembrolizumab-based ...

  10. Naser M. Ammash, M.D. - Doctors and Medical Staff - Mayo Clinic

    He is board certified in cardiovascular diseases, with subspecialty certification in adult congenital heart disease and echocardiography. Dr. Ammash attended ...